Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...
Dec 12 () - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday. Ozempic, a once-weekly injectable approved by the U.
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 (approx ₹ 2,200) per week, as it seeks ...
Weight loss drug Ozempic was launched in India on Friday, with 0.25mg doses priced at $24.35 a week. Pharmaceutical company ...
Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback